AlphAIAlphAI — Financial news for AI agents
tradingview.comOCT 62 min read$OPCH

Option Care Health to Be Acquired for $32.05 Per Share by CD&R and McKesson

Option Care Health (OPCH) agreed to be acquired by an investor group led by affiliates of Clayton, Dubilier & Rice and McKesson for $32.05 per share in cash. The deal, subject to shareholder and regulatory approvals, is backed by $2.87 billion in equity commitments and debt financing. The transaction aims to accelerate growth and strategic scale.

Original reporting
tradingview.com
Published Oct 6, 2026, 12:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 12:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Option Care Health to Be Acquired for $32.05 Per Share by CD&R and McKesson — source image
Source · tradingview.com
Decision brief

The 30-second read

$OPCHBullishHigh
01

Why it matters

The acquisition creates a larger integrated platform, potentially improving scale efficiencies and payer negotiations.

02

Market read

The deal is a material M&A event in the U.S. healthcare sector, likely moving OPCH stock toward the $32.05 offer price and prompting modest reassessment of McKesson's balance sheet.

03

What to watch

Potential antitrust concerns and integration risks could affect long‑term value.

Relevance 9/10Novelty 9/10Timing: immediate, effective upon announcement

Background

Option Care Health (OPCH) operates a network of home health and hospice facilities; McKesson is a major healthcare distributor and services provider.

Company-level read

Ticker impact

$OPCHBullishHigh confidence
Context

Option Care Health disclosed a definitive merger agreement to be acquired at $32.05 cash per share, a new primary M&A announcement.

Expected impact

upward pressure as the stock trades toward $32.05 per share

Evidence & confidence

The cash offer represents a premium to current trading levels; arbitrage traders will bid up the price.

$MCKNeutralMedium confidence
Context

McKesson is a lead investor in the consortium acquiring Option Care Health, making it a direct party to the transaction.

Expected impact

slight pressure or flat as the market assesses financing impact

Evidence & confidence

The deal involves a $2.87 B equity commitment; impact on McKesson's balance sheet is limited relative to its size.

Market effects

Sector

Consolidation in the home health and post‑acute care sector may spur further M&A activity.

Regional

U.S. healthcare services market sees increased M&A scrutiny.

Global

Limited to U.S. healthcare investors, but signals private‑equity appetite for sector.

Counterpoint

What could challenge this read

If regulatory approvals stall, the deal could be delayed, capping upside for OPCH.

Key entities

  • Company
    Option Care Health

    Target of the acquisition, ticker OPCH.

  • Company
    McKesson

    Lead investor in the acquiring consortium, ticker MCK.

  • Private Equity
    Clayton, Dubilier & Rice

    Co‑lead investor in the acquisition consortium.

Read at source← All news

StoryCD&R and McKesson agree to acquire Option Care Health

Also covered by

5 outlets

Related articles

OCT 10
$OPCHMed

Key deals this week: Option Care Health, PTC, Energy Transfer and more

Service Properties Trust (SSVC) received a $2.0B acquisition offer from TKO LLC. Viatris (VTRS) agreed to buy Pacira BioSciences (PCRX) for $1.65B. Option Care Health (OPCH) surged 34% after a $5.8B acquisition deal with CD&R and McKesson (MCK). Energy Transfer (ET) will acquire Vaquero Midstream for $2.625B. Emera (EMA) and Canadian Utilities (CDUAF) agreed to a $10B merger. Cenovus Energy (CVE) will acquire Athabasca Oil (ATHOF) for ~$5.7B.

tradingview.com1 min
OCT 10
$OPCHHighAI 9/10

Option Care Health Sold for $5.8B in CD&R-McKesson Deal

Option Care Health (OPCH) is being acquired by CD&R and McKesson (MCK) for $5.8B, or $32.05 per share, a 37% premium. The deal, expected to close in 2027, values the company at $5.8B. Option Care Health will operate independently post-acquisition. The company reported $5.6B in 2025 revenue and $207.6M in net income, with modest growth in 2026. The acquisition aligns with McKesson's strategy to expand access to innovative therapies.

hoodline.com2 min
OCT 9
$MCKHighAI 9/10

McKesson (MCK) Joins $5.8 Billion Option Care Health (OPCH) Acquisition. Is the Valuation Justified?

McKesson (MCK) is acquiring Option Care Health (OPCH) for $5.8B, including debt, at $32.05 per share, a 37% premium. McKesson and private equity firm CD&R will own 49% and 51% respectively. The deal expands McKesson's specialty healthcare services. McKesson's Q1 2027 revenue was $105.4B, beating estimates, with adjusted EPS up 20% YoY to $9.93. The company raised its fiscal 2027 adjusted EPS guidance to $44.20-$45.00.

finance.yahoo.com2 min
OCT 8
$MCKHighAI 9/10

McKesson & CD&R Acquire Leading US Home-Infusion Platform

McKesson and private equity firm CD&R will acquire Option Care Health, a US home-infusion care provider, for $5.8bn. CD&R will take a majority stake, while McKesson invests $1.4bn for a minority stake. The deal values Option Care Health at $32.05 per share and is expected to close in H1 2027. McKesson aims to leverage the acquisition to expand its specialty care offerings.

healthcare-digital.com3 min
OCT 7
$OPCHHighAI 9/10

Infusion therapy provider being acquired in $5.8 billion deal

Option Care Health (OPCH) is being acquired by CD&R and McKesson in a $5.8 billion deal, expected to close in early 2027. CD&R will hold majority ownership, with McKesson holding a minority stake. Option Care Health shares were trading at $31.02, up from $23.34 before the acquisition news. The company will remain separate but will delist from Nasdaq post-deal.

wfmz.com2 min